Clinical, economic, and humanistic burden of asthma in Canada: A systematic review

BMC Pulmonary Medicine

Volumn 13, Issue 1, 2013, Pages

  Ismaila, Afisi S ^a,b   Sayani, Amyn P ^a   Marin, Mihaela ^c   Su, Zhen ^d  

^a GLAXOSMITHKLINE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Product Value Strategy Consulting   (Canada)

^d Medical Affairs   (United States)

Author keywords

Asthma; Burden of illness; Costs; Literature review; Quality of life

Indexed keywords

ARTICLE; ASTHMA; CANADA; DISTRESS SYNDROME; FUNCTIONAL DISEASE; HEALTH CARE COST; HEALTH ECONOMICS; HOSPITALIZATION; HUMAN; PRESCRIPTION; PREVALENCE; PRODUCTIVITY; QUALITY CONTROL; QUALITY OF LIFE; SYSTEMATIC REVIEW; WORK;

ASTHMA; CANADA; COST OF ILLNESS; DRUG PRESCRIPTIONS; EMERGENCY SERVICE, HOSPITAL; HEALTH CARE COSTS; HEALTH SERVICES; HOSPITALIZATION; HUMANS; OFFICE VISITS; QUALITY OF LIFE;

EID: 84889025261     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-13-70     Document Type: Article

References (63)

1. Masoli M, Fabian D, Holt S, Beasley R. Global initiative for asthma (GINA) program. Allergy 2004, 59:469-78. 10.1111/j.1398-9995.2004.00526.x, 15080825.
2. Gershon A, Wang C, Cicutto L, To T. The burden of asthma: Can it be eased?. Healthc Q 2007, 10:22-4.
3. Asthma Society of Canada Asthma facts and statistics 2012, Available at http://www.asthma.ca/corp/newsroom/pdf/asthmastats.pdf Last accessed August 27, Asthma Society of Canada.
4. Lougheed MD, Lemiere C, Ducharme FM, Licskai C, Dell SD, Rowe BH, Fitzgerald M, Leigh R, Watson W, Boulet LP. Canadian thoracic society asthma clinical assembly: Canadian thoracic society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J 2012, 19:127-164. 3373283, 22536582.
5. Statistics Canada: asthma 2010, website [http://www.statcan.gc.ca/pub/82-625-x/2011001/article/11458-eng.htm ].
6. To T, Gershon A, Cicutto L, Wang CN. The burden of asthma: can it be eased? The Ontario record. Healthc Q 2007, 10:22-4.
7. Millar WJ, Gerry BH, Statistics Canada Childhood asthma. Health Rep 1998, 10:12. http://www5.statcan.gc.ca/bsolc/olc-cel/olc-cel?catno=82-003-x19980034137&lang=eng.pdf, Statistics Canada.
8. Garner R, Kohen D, Statistics Canada Changes in the prevalence of childhood asthma. Health Rep 2008, catalogue 82-003-X. http://www.statcan.gc.ca/pub/82-003-x/2008002/article/10551-eng.pdf, Statistics Canada.
9. Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM. Economic burden of asthma: a systematic review. BMC Pulm Med 2009, 9:24. 10.1186/1471-2466-9-24, 2698859, 19454036.
10. Sadatsafavi M, Lynd L, Marra C, Carleton B, Tan WC, Sullivan S, Fitzgerald JM. Direct health care costs associated with asthma in British Columbia. Can Respir J 2010, 17:74-80. 2866215, 20422063.
11. Bousquet J, Bousquet PJ, Godard P, Daures JP. The public health implications of asthma. Bull World Health Organ 2005, 83:548-54. 2626301, 16175830.
12. Braman SS. The global burden of asthma. Chest 2006, 130:4S-12S. 10.1378/chest.130.1_suppl.4S, 16840363.
13. Juniper EF. Using humanistic health outcomes data in asthma. Pharmacoecon 2001, 19(Suppl 2):13-9.
14. National Institute for Health and Clinical Excellence The guidelines manual (January 2009) 2011, London: National Institute for Health and Clinical Excellence, Available at http://www.nice.org.uk, National Institute for Health and Clinical Excellence.
15. STROBE Statement (2009) 2012, Available at http://www.strobe-statement.org/index.php?id=available-checklists.
16. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M. STROBE initiative: strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 2007, 4:e297. 10.1371/journal.pmed.0040297, 2020496, 17941715.
17. Statistics Canada Consumer price index 2012, Available at http://www.statcan.gc.ca, Statistics Canada.
18. Blais L, Beauchesne M-F, Forget A. Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol. Respir Med 2009, 103:237-43. 10.1016/j.rmed.2008.09.001, 18930647.
19. Rosychuk R, Voaklander D, Klassen T, Senthilselvan A, Marrie TJ, Rowe BH. Asthma presentations by children to emergency departments in a Canadian province: a population-based study. Pediatr Pulmonol 2010, 45:985-92. 10.1002/ppul.21281, 20632409.
20. Crighton EJ, Mamdani MM, Upshur RE. A population based time series analysis of asthma hospitalisations in Ontario, Canada: 1988 to 2000. BMC Health Serv Res 2001, 1:7. 10.1186/1472-6963-1-7, 57008, 11580873.
21. Ungar W, Paterson J, Gomes T, Bikangaga P, Gold M, To T, Kozyrskyj AL. Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma. Ann Allergy Asthma Immunol 2011, 106:17-23. 10.1016/j.anai.2010.10.006, 21195940.
22. Disano J, Goulet J, Muhajarine N, Neudorf C, Harvey J. Social-economic status and rates of hospital admission for chronic disease in urban Canada. Can Nurse 2010, 106:24-9.
23. Rowe BH, Bota GW, Clark S, Camargo CA. Multicenter airway research collaboration investigators. Comparison of Canadian vs. American emergency department visits for acute asthma. Can Respir J 2007, 14:331-7. 2676405, 17885692.
24. To T, Dell S, Dick P, Cicutto L. The burden of illness experienced by young children associated with asthma: a population-based cohort study. J Asthma 2008, 45:45-9. 10.1080/02770900701815743, 18259995.
25. Lemiere C, Forget A, Dufour M, Boulet LP, Blais L. Characteristics and medical resource use of asthmatic subjects with and without work-related asthma. J Allergy Clin Immunol 2007, 120:1354-9. 10.1016/j.jaci.2007.07.043, 17889289.
26. To T, Gershon A, Wang C, Dell S, Cicutto L. Persistence and remission in childhood asthma: a population-based asthma birth cohort study. Arch Pediatr Adolesc Med 2007, 161:1197-204. 10.1001/archpedi.161.12.1197, 18056566.
27. Agha M, Glazier R, Guttmann A. Relationship between social inequalities and ambulatory care-sensitive hospitalisations persists for up to 9 years among children born in a major Canadian urban center. Ambul Pediatr 2007, 7:258-62. 10.1016/j.ambp.2007.02.005, 17512888.
28. Lougheed M, Garvey N, Chapman K, Cicutto L, Dales R, Day AG, Hopman WM, Lam M, Sears MR, Szpiro K, To T, Paterson NA. Ontario respiratory outcomes research network: the Ontario asthma regional variation study: emergency department visit rates and the relation to hospitalization rates. Chest 2006, 129:909-17. 10.1378/chest.129.4.909, 16608938.
29. Dik N, Anthonisen N, Manfreda J, Roos LL. Physician-diagnosed asthma and allergic rhinitis in Manitoba: 1985-1998. Ann Allergy Asthma Immunol 2006, 96:69-75. 10.1016/S1081-1206(10)61042-3, 16440535.
30. Sin DD, Tu JV. Inhaled corticosteroid therapy reduces the risk of rehospitalisation and all-cause mortality in elderly asthmatics. Eur Respir J 2001, 17:380-5. 10.1183/09031936.01.17303800, 11405515.
31. Rowe BH, Villa Roel C, Abu-Laban RB, Stenstrom R, Mackey D, Stiell IG, Campbell S, Young B. Admissions to Canadian hospitals for acute asthma: a prospective, multicenter study. Can Respir J 2010, 17:25-30. 2866213, 20186368.
32. Sin D, Svenson L, Cowie RL, Man SF. Can universal access to healthcare eliminate health inequities between children of poor and nonpoor families?: A case study of childhood asthma in Alberta. Chest 2003, 124:51-6. 10.1378/chest.124.1.51, 12853501.
33. Ungar WJ, Coyte PC. Pharmacy medication monitoring program advisory board. Prospective study of the patient-level cost of asthma care in children. Pediatr Pulmonol 2001, 32:101-8. 10.1002/ppul.1095, 11477726.
34. Anis AH, Guh D, Stieb D, Leon H, Beveridge RC, Burnett RT, Dales RE. The costs of cardiorespiratory disease episodes in a study of emergency department use. Can J Public Health 2000, 91:103-6.
35. Boulet L, FitzGerald J, McIvor R, Zimmerman S, Chapman KR. Influence of current or former smoking on asthma management and control. Can Respir J 2008, 15:275-9. 2679551, 18716691.
36. Klomp H, Lawson J, Cockcroft D, Chan BT, Cascagnette P, Gander L, Jorgenson D. Examining asthma quality of care using a population-based approach. CMAJ 2008, 178:1013-21. 10.1503/cmaj.070426, 2276554, 18390944.
37. Iron K, Manuel D, Williams J. Using a linked data set to determine the factors associated with utilization and costs of family physician services in Ontario: effects of self-reported chronic conditions. Chronic Dis Can 2003, 24:124-32.
38. Anis AH, Lynd LD, Wang XH, King G, Spinelli JJ, Fitzgerald M, Bai T, Paré P. Double trouble: impact of inappropriate use of asthma medication on the use of healthcare resources. CMAJ 2001, 164:625-31. 80815, 11258208.
39. Baibergenova A, Thabane L, Akhtar-Danesh N, Levine M, Gafni A, Moineddin R, Pulcins I. Effect of gender, age, and severity of asthma attack on patterns of emergency department visits due to asthma by month and day of the week. Eur J Epidemiol 2005, 20:947-56. 10.1007/s10654-005-3635-6, 16284873.
40. Lynd LD, Sandford AJ, Kelly EM, Paré PD, Bai TR, Fitzgerald JM, Anis AH. Reconcilable differences: a cross-sectional study of the relationship between socioeconomic status and the magnitude of short-acting beta-agonist use in asthma. Chest 2004, 126:1161-8. 10.1378/chest.126.4.1161, 15486378.
41. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax 2002, 57:880-4. 10.1136/thorax.57.10.880, 1746208, 12324675.
42. Seung S, Mittmann N. Urgent care costs of uncontrolled asthma in Canada, 2004. Can Respir J 2005, 12:435-6.
43. Blais L, Kettani F-Z, Lemière C, Beauchesne MF, Perreault S, Elftouh N, Ducharme FM. Inhaled corticosteroids vs. leukotriene-receptor antagonists and asthma exacerbations in children. Respir Med 2011, 105:846-55. 10.1016/j.rmed.2010.12.007, 21196105.
44. Sin DD, Tu JV. Underuse of inhaled steroid therapy in elderly patients with asthma. Chest 2001, 119:720-5. 10.1378/chest.119.3.720, 11243948.
45. Rowe B, Voaklander D, Wang D, Senthilselvan A, Klassen TP, Marrie TJ, Rosychuk RJ. Asthma presentations by adults to emergency departments in Alberta, Canada: a large population-based study. Chest 2009, 135:57-65. 10.1378/chest.07-3041, 18689586.
46. Malo J, L'Archevêque J, Ghezzo H. Direct costs of occupational asthma in Quebec between 1988 and 2002. Can Respir J 2008, 15:413-6. 2682162, 19107240.
47. Kohen D. Asthma and school functioning. Health Rep 2010, 21:35-45.
48. Thanh NX, Ohinmaa A, Yan C. Asthma-related productivity losses in Alberta, Canada. J Asthma Allergy 2009, 2:43-8. 3048601, 21437143.
49. Ungar WJ, Coyte PC. Measuring productivity loss days in asthma patients the pharmacy medication monitoring program and advisory board. Health Econ 2000, 9:37-46. 10.1002/(SICI)1099-1050(200001)9:1<37::AID-HEC483>3.0.CO;2-S, 10694758.
50. Zimmerman B, D'Urzo A, Bérubé D. Efficacy and safety of formoterol turbuhaler® when added to inhaled corticosteroid treatment in children with asthma. Pediatr Pulmonol 2004, 37:122-7. 10.1002/ppul.10404, 14730657.
51. Miedinger D, Lavoie KL, L'Archeveque J, Ghezzo H, Malo JL. Identification of clinically significant psychological distress and psychiatric morbidity by examining quality of life in subjects with occupational asthma. Health Qual Life Outcomes 2011, 9:76. 10.1186/1477-7525-9-76, 3196900, 21939509.
52. Lavoie K, Cartier A, Labrecque M, Bacon SL, Lemière C, Malo JL, Lacoste G, Barone S, Verrier P, Ditto B. Are psychiatric disorders associated with worse asthma control and quality of life in asthma patients?. Respir Med 2005, 99:1249-57. 10.1016/j.rmed.2005.03.003, 16140225.
53. Bacon S, Bouchard A, Loucks E, Lavoie KL. Individual-level socioeconomic status is associated with worse asthma morbidity in patients with asthma. Respir Res 2009, 10:125. 10.1186/1465-9921-10-125, 2806364, 20017907.
54. McTaggart-Cowan HM, Marra CA, Yang Y, Brazier JE, Kopec JA, FitzGerald JM, Anis AH, Lynd LD. The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status. Qual Life Res 2008, 17:453-62. 10.1007/s11136-008-9309-6, 18274882.
55. Rowe B, Wong E, Blitz S, Diner B, Mackey D, Ross S, Senthilselvan A. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. Acad Emerg Med 2007, 14:833-40. 10.1111/j.1553-2712.2007.tb02313.x, 17898245.
56. Yacoub MR, Lavoie K, Lacoste G, Daigle S, L'Archevêque J, Ghezzo H, Lemière C, Malo JL. Assessment of impairment/disability due to occupational asthma through a multidimensional approach. Eur Respir J 2007, 29:889-96. 10.1183/09031936.00127206, 17182649.
57. Lavoie K, Bacon S, Barone S, Cartier A, Ditto B, Labrecque M. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both?. Chest 2006, 130:1039-47. 10.1378/chest.130.4.1039, 17035436.
58. Lavoie K, Bacon S, Labrecque M, Cartier A, Ditto B. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med 2006, 100:648-57. 10.1016/j.rmed.2005.08.001, 16159709.
59. Mo F, Choi B, Li F, Merrick J. Using Health Utility Index (HUI) for measuring the impact on health-related quality of life (HRQL) among individuals with chronic diseases. Sci World J 2004, 4:746-57.
60. Fitzgerald JM, Shragge D, Haddon J, Jennings B, Lee J, Bai T, Pare P, Kassen D, Grunfeld A. A randomized, controlled trial of high dose, inhaled budesonide vs. oral prednisone in patients discharged from the emergency department following an acute asthma exacerbation. Can Respir J 2000, 7:61-7.
61. Williams AE, Agier L, Wiklund I, Frith L, Gul N, Juniper E. Transcultural and measurement evaluation of the asthma quality-of-life questionnaire. Health Outcomes Research in Medicine 2010, 1:e69-e79.
62. Lavoie K, Bouthillier D, Bacon S, Lemière C, Martin J, Hamid Q, Ludwig M, Olivenstein R, Ernst P. Psychologic distress and maladaptive coping styles in patients with severe vs moderate asthma. Chest 2010, 137:1324-31. 10.1378/chest.09-1979, 20097803.
63. Miedinger D, Lavoie K, L'Archevêque J, Ghezzo H, Zunzunuegui MV, Malo JL. Quality-of-life, psychological, and cost outcomes 2 years after diagnosis of occupational asthma. J Occup Environmental Med 2011, 53:231-8.